DOJ Says Wash. 340B Drug Law Is Preempted In Novartis Suit

By Ben Adlin · April 27, 2026, 10:58 PM EDT

The U.S. Department of Justice waded into a dispute between pharmaceutical giants and the state of Washington on Monday, arguing that federal law preempts a new state law that expands discounts...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Statement of Interest

Case Information

Case Title

Novartis Pharmaceuticals Corporation v. Brown

Case Number

Court

Washington Western

Nature of Suit

Constitutional - State Statute

Date Filed

March 25, 2026

Recent Articles By Ben

April 20, 2026
Providence Health's Sour Investment Cost $70M, Retirees Say
April 15, 2026
Hims & Hers Providers Can't Duck Suit Over Student's Suicide
April 08, 2026
Ed. Dept. Says It's Not Required To Fund $1B In Youth Grants
April 07, 2026
Insurer Premera Accuses Clinic Of Misusing No Surprises Act
April 01, 2026
9th Circ. Revives Aya Health Arbitrations In Nurses' Wage Suit
March 20, 2026
Eli Lilly Beats 9th Circ. Appeal Over Brain Bleed After Cialis
March 19, 2026
HHS Can't Block Trans Care Under Kennedy Edict, Court Says
March 05, 2026
Telehealth Co. Swaps In Gordon Rees In Novo's GLP-1 Fight
March 03, 2026
Death From Stem Cell Treatment For ALS Draws $24M Verdict
January 22, 2026
FDA Action Shouldn't Halt Amazon Labeling Suit, Plaintiffs Say